Jani Saunavaara
Papers
2
Total Citations
38
H-Index
2
About
Jani Saunavaara is a leading researcher in interventional oncology, specializing in MRI-guided transurethral ultrasound ablation (TULSA) for prostate cancer. His work focuses on advancing minimally invasive, image-guided therapies that precisely target tumors while preserving healthy tissue. Saunavaara’s major contributions include pioneering the clinical evaluation of TULSA for organ-confined prostate cancer, demonstrating its safety, accuracy, and short-term efficacy in landmark studies. His 2019 paper on the feasibility of lesion-targeted TULSA, with 30 citations, established foundational evidence for this emerging technique. He further characterized acute and subacute post-ablation MRI findings, providing critical insights into treatment response and tissue evolution. These studies have helped shape the adoption of TULSA as a precise alternative to surgery or radiation, reducing toxicity and improving patient outcomes. Saunavaara’s work bridges radiology and urology, offering students and researchers a model for translating advanced imaging into targeted cancer therapy. His contributions continue to influence the development of focal therapies, making him a key figure in the evolution of prostate cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2